https://markets.businessinsider.com/news/stocks/monopar-therapeutics-sees-cash-runway-through-december-31-2026-1034533556
Monopar Therapeutics sees cash runway through December 31, 2026 | Markets Insider
Cash, cash equivalents and short-term investments as of December 31, 2024, were $60.2 million. Monopar expects that its current funds will be su...
therapeuticsseescashrunway
https://ir.monopartx.com/
Investor Relations :: Monopar Therapeutics Inc. (MNPR)
investor relationstherapeuticsincmnpr